Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contezolid Tablets in Adult Pneumonia (Single-arm PK and Efficacy Study)
ChiCTR2300067397Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of contezolid in pneumonia and Pneumonia due to gram-positive bacteria, sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: Clinical effect and Microbiological efficacy. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
contezolid
03
Conditions
pneumoniaPneumonia due to gram-positive bacteria
Beyond the preview
Go deeper on ChiCTR2300067397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067397.